Comparison of the Effects of Cyproterone Compound-Spironolactone, Metformin and Pioglitazone on Serum Levels of High Sensitivity C-Reactive Protein and Complement System in Polycystic Ovarian Syndrome: A Randomized Double-blind Clinical Trial

Introduction: Polycystic ovarian syndrome (PCOS) is one of the most common hormonal disorders affecting women of reproductive age. Numerous studies have suggested the involvement of inflammation in the pathogenesis of PCOS. As a result, drugs with anti-inflammatory effects may offer therapeutic bene...

Descrición completa

Detalles Bibliográficos

Principais autores:	Mesbah Shams, Azar Sattarinezhad, Hossainali Rostamipour, Azar Purkhosrow, Elahe Sattarinezhad
Formato:	Artigo
Idioma:	Inglês
Publicado:	Mashhad University of Medical Sciences 2025-03-01
Series:	Reviews in Clinical Medicine
Assuntos:	polycystic ovarian syndrome inflammation cyproterone spironolactone metformin pioglitazone
Acceso en liña:	https://rcm.mums.ac.ir/article_25713_5347f0d1e233b545ef775316f975efc8.pdf
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!